152 related articles for article (PubMed ID: 1837117)
1. [Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation].
Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
Presse Med; 1991 Nov; 20(40):2025-7. PubMed ID: 1837117
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation.
Pol S; Legendre C; Saltiel C; Carnot F; Bréchot C; Berthelot P; Mattlinger B; Kreis H
J Hepatol; 1992 May; 15(1-2):202-6. PubMed ID: 1324270
[TBL] [Abstract][Full Text] [Related]
3. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients.
Huang CC; Liaw YF; Lai MK; Chu SH; Chuang CK; Huang JY
Transplantation; 1992 Apr; 53(4):763-5. PubMed ID: 1373534
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.
Pereira BJ; Milford EL; Kirkman RL; Quan S; Sayre KR; Johnson PJ; Wilber JC; Levey AS
N Engl J Med; 1992 Sep; 327(13):910-5. PubMed ID: 1325035
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of hepatitis C viremia in renal allograft recipients.
Mahmoud IM; Sobh MA; Amer GM; El-Chenawy FA; Gazareen SH; El-Sherif A; El-Sawy E; Ghoneim MA
Am J Nephrol; 1999; 19(5):576-85. PubMed ID: 10575187
[TBL] [Abstract][Full Text] [Related]
6. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
Bang BK; Yang CW; Yoon SA; Kim YS; Chang YS; Yoon YS; Koh YB
Nephron; 1995; 70(4):397-401. PubMed ID: 7477642
[TBL] [Abstract][Full Text] [Related]
8. [Liver impairment in kidney transplant recipients. 1. Prevalence and clinical significance of hepatitis C].
Ihara H; Kubo M; Miyamoto I; Nojima M; Koike H; Yabumoto H; Arima M; Ikoma F; Hiraoka K; Inagaki O
Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1181-8. PubMed ID: 7505346
[TBL] [Abstract][Full Text] [Related]
9. Transmission of hepatitis C virus by organ transplantation.
Pereira BJ; Milford EL; Kirkman RL; Levey AS
N Engl J Med; 1991 Aug; 325(7):454-60. PubMed ID: 1649402
[TBL] [Abstract][Full Text] [Related]
10. HBV and HCV infection in kidney transplant recipients.
Frider B; Castaño G; Sookoian S; Livellara B; Kina M; Sabatiello R; Castiglione T; Iotti R; Vázquez MC
Acta Gastroenterol Latinoam; 1993; 23(2):75-81. PubMed ID: 8249531
[TBL] [Abstract][Full Text] [Related]
11. Influence of hepatitis B and hepatitis C virus infection on the outcome of kidney transplantation.
Yuan CH; Liu YF; Li GC
Chin Med Sci J; 2005 Jun; 20(2):129-32. PubMed ID: 16075755
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection among kidney transplant recipients.
Ponz E; Campistol JM; Bruguera M; Barrera JM; Gil C; Pinto JB; Andreu J
Kidney Int; 1991 Oct; 40(4):748-51. PubMed ID: 1720826
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus infection in liver allograft recipients.
Caccamo L; Colledan M; Gridelli B; Rossi G; Doglia M; Gatti S; Ghidoni P; Lucianetti A; Lunghi G; Maggi U
Arch Virol Suppl; 1993; 8():291-304. PubMed ID: 7505145
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis B and C virus infections on kidney transplantation: a single center experience.
Santos L; Alves R; Macario F; Parada B; Campos M; Mota A
Transplant Proc; 2009 Apr; 41(3):880-2. PubMed ID: 19376378
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation.
Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ
Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibody to hepatitis C virus in renal transplant recipients.
Roth D; Fernandez JA; Burke GW; Esquenazi V; Miller J
Transplantation; 1991 Feb; 51(2):396-400. PubMed ID: 1847250
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis B and C virus on kidney transplantation outcome.
Mathurin P; Mouquet C; Poynard T; Sylla C; Benalia H; Fretz C; Thibault V; Cadranel JF; Bernard B; Opolon P; Coriat P; Bitker MO
Hepatology; 1999 Jan; 29(1):257-63. PubMed ID: 9862875
[TBL] [Abstract][Full Text] [Related]
19. [Incidence of hepatitis C virus in kidney transplantation recipients].
Catelle A; Edert D; Renoult E; Cao Huu T
Agressologie; 1992; 33 Spec No 2():99-102. PubMed ID: 1340101
[TBL] [Abstract][Full Text] [Related]
20. Risk of liver disease in HCV-seropositive kidney transplant recipients.
Rohr MS; Lesniewski RR; Rubin CA; Johnson RG; Heise ER; McDonald JC; Adams PL
Ann Surg; 1993 May; 217(5):512-6; discussion 516-7. PubMed ID: 8387764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
